Cambridge Investment Research Advisors, Inc. Bio Techne Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,511 shares of TECH stock, worth $180,917. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,511
Previous 2,906
13.59%
Holding current value
$180,917
Previous $208,000
3.37%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding TECH
# of Institutions
598Shares Held
151MCall Options Held
195KPut Options Held
53.2K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.32 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.08 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$679 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$461 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.66MShares$336 Million0.03% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.83B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...